TickerFacts.

Abeona Therapeutics Inc. (ABEO): Long-Term Debt

Annual figures by period end, from SEC filings.

$20.04M
As of 2025-12-31
$14.99M
As of 2026-06-30
2024-12-31: $18.96M2025-12-31: $20.04M$20.04M
2024-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$20.04M+5.7%2026-03-17, Balance as of period end
2024-12-31$18.96Mn/a2026-03-17, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Abeona Therapeutics Inc. (ABEO)2025-12-31$20.04M+5.7%
Puma Biotechnology, Inc. (PBYI)2025-12-31$22.68M-66.7%
Pliant Therapeutics, Inc. (PLRX)2025-12-31$0-100.0%
Evolus, Inc. (EOLS)2025-12-31$146.10M+20.2%
COMPASS Pathways plc (CMPS)2025-12-31$31.63M+4.9%
Lifecore Biomedical, Inc. (LFCR)2025-05-25$130.44M+4.6%
UroGen Pharma Ltd. (URGN)2025-12-31$125.00Mn/a
Verastem, Inc. (VSTM)2024-12-31$40.72M+1.6%
Savara Inc (SVRA)2025-12-31$29.91M+12.4%

Compare ABEO, PBYI, PLRX, EOLS side by side · Screen every company in Pharmaceutical Preparations ↗